Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Aging (Albany NY) ; 16(9): 7870-7888, 2024 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-38709288

RESUMO

BMP9 has demonstrated significant osteogenic potential. In this study, we investigated the effect of Leptin on BMP9-induced osteogenic differentiation. Firstly, we found Leptin was decreased during BMP9-induced osteogenic differentiation and serum Leptin concentrations were increased in the ovariectomized (OVX) rats. Both in vitro and in vivo, exogenous expression of Leptin inhibited the process of osteogenic differentiation, whereas silencing Leptin enhanced. Exogenous Leptin could increase the malonylation of ß-catenin. However, BMP9 could increase the level of Sirt5 and subsequently decrease the malonylation of ß-catenin; the BMP9-induced osteogenic differentiation was inhibited by silencing Sirt5. These data suggested that Leptin can inhibit the BMP9-induced osteogenic differentiation, which may be mediated through reducing the activity of Wnt/ß-catenin signalling via down-regulating Sirt5 to increase the malonylation level of ß-catenin partly.


Assuntos
Regulação para Baixo , Fator 2 de Diferenciação de Crescimento , Leptina , Osteogênese , Sirtuínas , Via de Sinalização Wnt , beta Catenina , Animais , beta Catenina/metabolismo , beta Catenina/genética , Sirtuínas/metabolismo , Sirtuínas/genética , Feminino , Ratos , Osteogênese/efeitos dos fármacos , Leptina/metabolismo , Leptina/farmacologia , Fator 2 de Diferenciação de Crescimento/metabolismo , Via de Sinalização Wnt/efeitos dos fármacos , Ovariectomia , Diferenciação Celular/efeitos dos fármacos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA